Vector for expression of heterologous protein and methods for ex

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 691, 435 911, 43525233, 4353201, C42N 1509

Patent

active

060689935

ABSTRACT:
The present invention relates to a vector for expression of a heterologous protein by a Gram negative bacteria, wherein the vector includes a nucleic acid such as DNA encoding the following: an origin of replication region; optionally and preferably a selection marker; a promoter; an initiation region such as translation initiation region and/or a ribosome binding site, at least one restriction site for insertion of heterologous nucleic acid, e.g. DNA, encoding the heterologous protein, and a transcription terminator. The inventive vector may contain DNA encoding the heterologous protein, e.g., pro-insulin such as pro-insulin with a His tag. Additionally, the invention provides a method for extracting a recombinant protein from within a recombinant Gram negative bacteria having a cell membrane, without lysing the bacteria, as well as a method for purifying an isolated recombinant human insulin, wherein the isolated recombinant human pro-insulin is subjected to sulfitolysis, Ni-chelation chromatography, renaturation, limited proteolysis and chromatography separation to provide purified, isolated, recombinant human insulin.

REFERENCES:
patent: 4503155 (1985-03-01), Miller et al.
patent: 4578355 (1986-03-01), Rosenberg
patent: 4599197 (1986-07-01), Wetzel
patent: 4624926 (1986-11-01), Inouye et al.
patent: 4704362 (1987-11-01), Itakura et al.
patent: 4732859 (1988-03-01), Hershberger et al.
patent: 4734368 (1988-03-01), Schindler
patent: 4766066 (1988-08-01), Kuhstoss et al.
patent: 4766205 (1988-08-01), Gosh-Dastidar
patent: 4766224 (1988-08-01), Rausch
patent: 4870013 (1989-09-01), Gelfand et al.
patent: 4877830 (1989-10-01), Dobeli et al.
patent: 5032510 (1991-07-01), Kovacevic et al.
patent: 5063158 (1991-11-01), Schoner et al.
patent: 5115102 (1992-05-01), Haymore et al.
patent: 5223408 (1993-06-01), Goeddel et al.
patent: 5256546 (1993-10-01), Aviv et al.
patent: 5258287 (1993-11-01), Baxter et al.
patent: 5262322 (1993-11-01), Liu et al.
patent: 5310663 (1994-05-01), Dobeli et al.
patent: 5328891 (1994-07-01), Baxter et al.
patent: 5460954 (1995-10-01), Lee et al.
patent: 5534428 (1996-07-01), Longo et al.
patent: 5602034 (1997-02-01), Tekkamp-Olson
patent: 5648235 (1997-07-01), Zurr et al.
Amann et al. Gene vol. 69, pp. 301-315, 1988.
Mertens et al. Gene vol. 164, pp. 9-15, Oct. 1995.
Lewin, B. Genes IV. Oxford University Press. Cambridge, MA. Chapter 15, pp. 284-386, 1990.
New England Biolabs 1995 catalog, pp. 16, 24, 31, 40, 44, and 49, 1995.
Nucleic Acids Research, vol. 18, No. 4, p. 1070.
Microbiological Reviews, vol. 60, No. 3, Sep. 1996, pp. 512-538.
Tekamp-Olson, U.S. Patent No. 5,602,034, issued Feb. 11, 1997; Expression and Secretion of Heterologous Proteins In Yeast Employing Trunicated Alpha-Factor Leader Sequences.
Schoner et al., U.S. Patent No. 5,063,158, issued Nov. 5, 1991; Recombinant DNA Expression Vector Comprising Both Transcriptional and Translation Activating Sequences.
Kovacevic et al., U.S. Patent No. l 5,032,510, issued Jul. 16, 1991; Method for Expression and Secretion in Bacillus.
Kuhstoss et al., U.S. Patent No. 4,766,066, issued Aug. 23, 1988; Method of Using Bacteriphage Lambda P Promoter to Produce a Functional Polypeptide in Streptomyces.
Hershberger et al., U.S. Patent No. 4,732,859, issued Mar. 22, 1988; Method for Conferring Bacteriophage Resistance to Bacteria.
Itakura et al., U.S. Patent No. 4,704,362, issued Nov. 3, 1987; Recombinant Cloning Vehicle Microbial Polypeptide Expression.
Inouye et al., U.S. Patent No. 4,624,926, issued Nov. 25, 1986; Novel Cloning Vehicles For Polypeptide Expression in Microbial Hosts.
Aviv et al., U.S. Patent No. 5,256,546, issued Oct. 26, 1993; Bacterial Expression of Porcine Growth Hormone.
Zurr et al., U.S. Patent No. 5,648,235, issued Jul. 15, 1997; Method and Means For the Production of Gene Products, Novel Recombinant DNA Vectors Therefore and Kits Employing Them.
Gelfand et al., U.S. Patent No. 4,870,013, issued Sep. 26, 1989; SV40 Early and RSV Promoters Useful in Saccharomyces Expression.
Miller et al., U.S. Patent No. 4,503,155, issued Mar. 5, 1985; Multifunctional, Cloning Vectors For Use In Streptomyces, Bacillus, and E. Coli .
Longo et al., U.S. Patent No. 5,534,428, issued Jul. 9, 1996; Cloned SSTI/SACI Restriction-Modification System.
Steven K. Rausch, U.S. Patent No. 4,766,224, issued Aug. 23, 1988; Purification and Activation of Proteins From Insoluble Inclusion Bodies.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Vector for expression of heterologous protein and methods for ex does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vector for expression of heterologous protein and methods for ex, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vector for expression of heterologous protein and methods for ex will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1909312

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.